Olin Stock Drops 19% After Q2 Loss, Freeport Outage Hit

NEW YORK, August 1 —

Olin Corporation (OLN) shares fell 19% on July 31 after Q2 2026 results filed with the SEC showed an equipment failure at the company's Freeport, Texas vinyl chloride monomer facility had erased $40 million in adjusted EBITDA from a quarter the balance sheet could not absorb. Behind the operational miss: $3.41 billion in total debt against $180 million in cash, a trailing twelve-month EPS of negative $1.73, and a pending all-stock merger with Huntsman Corporation that adds integration complexity at precisely the moment management can least afford distraction.

The $60 Million Two-Quarter Hole

The Freeport outage is not a single-quarter problem. The equipment failure reduced Q2 adjusted EBITDA by $40 million, and the same facility carries a further $20 million EBITDA drag into Q3, with full capacity not expected until Q4 2026. Total impact from one unplanned event: $60 million across two consecutive quarters.

That number reframes the Q3 guidance. Olin guided Q3 adjusted EBITDA of $160 million to $200 million. At the $180 million midpoint, the Freeport drag represents roughly 11% of the quarter's earnings power. The lower end of that range likely assumes no incremental deterioration beyond the known outage. Investors who watched 19% of market capitalization disappear in a single session are being asked to trust that the Q4 repair timeline holds and nothing else goes wrong between now and then.

Leverage Is Where the Numbers Get Serious

Operational setbacks are manageable when the balance sheet has room. Olin's does not. The company carries $3.41 billion in total debt against $180 million in cash, is running a trailing twelve-month EPS of negative $1.73, and expects its leverage ratio to reach approximately 4.5 times by year-end 2026, driven by litigation-related cash payments. That is not a capital structure that absorbs incremental surprises gracefully.

At 4.5 times leverage, a $20 million quarterly EBITDA miss is not a rounding error; it is a solvency conversation. Two segments did provide genuine improvement: Olin's Epoxy business returned to positive earnings following pricing actions and structural cost reductions exceeding $50 million annually, achieved through new supply agreements and a plant closure, while Winchester benefited from stronger commercial ammunition demand, pricing increases, and tariffs that curtailed import competition. Both are real. Neither closes a $60 million two-quarter EBITDA gap on a balance sheet operating near 4.5 times leverage.

A Merger at the Worst Possible Moment

The Huntsman deal is strategically coherent. An all-stock combination targeting $400 million in synergies and a first-half 2027 close fits the chemical sector consolidation playbook. The problem is timing, not thesis. Management is now running plant repairs, litigation cash payments, and merger integration planning simultaneously; any one of those is a real bandwidth draw, and all three at once on a highly leveraged balance sheet is a harder ask.

The all-stock structure means existing Olin shareholders absorb dilution before any synergy benefits are visible. That $400 million synergy figure is a 2027-and-beyond story, useful for long-horizon holders and largely irrelevant to investors pricing the stock through the Q3 and Q4 recovery window. The Huntsman deal does not resolve the Freeport timeline. It runs parallel to it, adding its own execution demands along the way.

What Q4 Has to Deliver

The recovery thesis is straightforward: Freeport returns to full capacity in Q4, the $60 million EBITDA headwind lifts, leverage begins declining as litigation payments wind down, and the Huntsman synergy story moves into investor view. Every step in that sequence has to proceed on schedule, with no further operational surprises.

The risks are concrete. Equipment repairs can exceed original timelines. Litigation cash outflows drive the leverage ratio to approximately 4.5 times regardless of plant performance. Merger integration introduces its own costs. A further operational miss in Q4, on a balance sheet already running a trailing EPS of negative $1.73 and approaching 4.5 times leverage, would not invite patience from the market.

Q4 2026 EBITDA is the first real checkpoint. A number that shows the Freeport drag fully resolved and leverage trending in the right direction would mark the first credible signal that the recovery is tracking. Until then, multi-quarter EBITDA headwinds, elevated leverage, and an unfinished merger integration present a compounding case for caution rather than optimism.

Run the free Olin Corporation deep-dive →

dent research for informational purposes. It is not investment advice and not a recommendation to buy or sell any security.